As found for ASCT2, ATB0,+ may be up-regulated in cancer to meet the increasing demand of arginine (Gupta et al., 2005, 2006), representing a potential target of cancer therapy (Karunakaran et al., 2011). The gene discussed is SLC1A5; the disease is cancer.